PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,000,439 | -53.9% | 119,813 | -26.5% | 0.07% | -52.8% |
Q2 2023 | $2,168,219 | +224.6% | 163,024 | +7.8% | 0.14% | +132.8% |
Q2 2022 | $668,000 | +105.5% | 151,259 | +322.6% | 0.06% | +117.9% |
Q1 2022 | $325,000 | +577.1% | 35,793 | +1405.2% | 0.03% | +600.0% |
Q4 2021 | $48,000 | -96.9% | 2,378 | -96.1% | 0.00% | -96.5% |
Q3 2021 | $1,569,000 | +9.6% | 61,410 | +49.9% | 0.12% | +1.8% |
Q2 2021 | $1,432,000 | +12918.2% | 40,963 | +1762.0% | 0.11% | +11200.0% |
Q3 2018 | $11,000 | – | 2,200 | +2100.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 100 | -98.4% | 0.00% | -100.0% |
Q1 2016 | $52,000 | +5100.0% | 6,211 | +2288.8% | 0.01% | – |
Q2 2015 | $1,000 | -96.9% | 260 | -93.7% | 0.00% | -100.0% |
Q4 2014 | $32,000 | -11.1% | 4,097 | -45.0% | 0.01% | +100.0% |
Q3 2014 | $36,000 | +1700.0% | 7,447 | +1761.8% | 0.01% | – |
Q1 2014 | $2,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |